A. Shavit

Airway pharmacology and treatment, The Lancet, Respiratory Research, European Respiratory Journal, Journal of Allergy and Clinical Immunology
6
Role Title Level Year L/R
🐜 Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
41 auth. David J Jackson, L. Heaney, M. Humbert, B. Kent, A. Shavit, Lina Hiljemark, L. Olinger, David Cohen, A. Menzies-Gow, Stephanie Korn, Claus Kroegel, Cristiano Caruso, Ilaria Baglivo, S. Colantuono, David J Jackson, ... D. Skowasch, Fabiano Di Marco, F. Couturaud, F. Käßner, Iwona Cwiek, Markus Teber, Kornelia Knetsch, Jasmin Preuß, G. Devouassoux, Katrin Milger-Kneidinger, L. Heaney, Lukas Jerrentrup, M. Jandl, Hartmut Timmermann, Beatrice Probst, Maria D’Amato, Martin Hoffmann, Philippe Bonniaud, G. Beltramo, P. Girodet, Patrick Berger, Shuaib M Nasser, Stéphanie Fry, Sven P. Aries, Thomas Koehler, Timothy Harrison 		5 2023 5
🐜
🐜 Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study
13 auth. F. Mihălțan, Y. Adir, A. Antczak, Konstantinos Porpodis, V. Radulović, N. Pires, G. D. de Vries, A. Horner, S. De Bontridder, Yunqin Chen, ... A. Shavit, S. Alecu, Lukasz Adamek 		4 2019 4
🐜
🐜 Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
19 auth. David J Jackson, G. Pelaia, Benjamin Emmanuel, Trung N. Tran, David Cohen, Vivian H Shih, A. Shavit, D. Arbetter, R. Katial, A. P. Rabe, ... E. Garcia Gil, M. Pardal, J. Nuevo, Michael Watt, S. Boarino, S. Kayaniyil, C. Chaves Loureiro, A. Padilla-Galo, P. Nair 		4 2024 4
🐜
🐜 Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study
16 auth. David Jackson, G. Pelaia, A. Padilla-Galo, M. Watt, S. Kayaniyil, S. Boarino, J. S. Tena, V. Shih, Trung Nghia Tran, D. Arbetter, ... D. Cohen, R. Katial, J. Kwiatek, A. Shavit, B. Emmanuel, Parameswaran Nair 		2 2023 2
🐜
🐜 Durability of Benralizumab-induced remission in severe asthma: an analysis of the BORA study
7 auth. M. Lommatzsch, A. Shavit, Anaud Bourdin, J. Kwiatek, David Cohen, Delphine Leynaud, ... A. Menzies-Gow 		1 2023 1
🐜
🐢 Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
7 auth. F. Kanniess, L. Tamási, Robert R. Mroz, P. Bakakos, Susanne Tubis, Gustavo Resler Plat, ... A. Shavit 		1 2021 1
🐢